Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Advances in Therapy
|
July 28, 2022
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
Wei Xu, Shenmiao Yang, Constantine S Tam, et al.
Blood
|
July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Constantine S Tam, Judith Trotman, Stephen Opat, et al.
Journal of Hematology & Oncology
|
October 15, 2021
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
Keshu Zhou, Dehui Zou, Jianfeng Zhou, et al.
Cancer Medicine
|
September 14, 2023
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis
Yuqin Song, Keshu Zhou, Dehui Zou, et al.
Ejhaem
|
April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project
Briony Shaw, Eliza Chung, Cameron Wellard, et al.
Blood
|
February 23, 2022
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort
Constantine S Tam, John N Allan, Tanya Siddiqi, et al.
Occupational and Environmental Medicine
|
September 18, 2023
Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study
Michael K Odutola, Marina T van Leeuwen, Fiona J Bruinsma, et al.
Blood
|
June 13, 2012
E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis
Kamil Wolyniec, Jake Shortt, Elisa de Stanchina, et al.
Haematologica
|
March 7, 2024
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, et al.
European Journal of Haematology
|
December 20, 2022
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry
James Nguyen, Cameron Wellard, Eliza Chung, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Advances in Therapy
|
July 28, 2022
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
Wei Xu, Shenmiao Yang, Constantine S Tam, et al.
Blood
|
July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Constantine S Tam, Judith Trotman, Stephen Opat, et al.
Journal of Hematology & Oncology
|
October 15, 2021
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
Keshu Zhou, Dehui Zou, Jianfeng Zhou, et al.
Cancer Medicine
|
September 14, 2023
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis
Yuqin Song, Keshu Zhou, Dehui Zou, et al.
Ejhaem
|
April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project
Briony Shaw, Eliza Chung, Cameron Wellard, et al.
Blood
|
February 23, 2022
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort
Constantine S Tam, John N Allan, Tanya Siddiqi, et al.
Occupational and Environmental Medicine
|
September 18, 2023
Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study
Michael K Odutola, Marina T van Leeuwen, Fiona J Bruinsma, et al.
Blood
|
June 13, 2012
E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis
Kamil Wolyniec, Jake Shortt, Elisa de Stanchina, et al.
Haematologica
|
March 7, 2024
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, et al.
European Journal of Haematology
|
December 20, 2022
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry
James Nguyen, Cameron Wellard, Eliza Chung, et al.
Page
of 13